Open-Label Safety and Tolerability Study of INCB057643 in Subjects With Advanced Malignancies
Incyte Corporation
Incyte Corporation
Washington University School of Medicine
Novartis
Incyte Corporation
Masonic Cancer Center, University of Minnesota
Barbara Ann Karmanos Cancer Institute